Related Experiment Video

Updated: Aug 15, 2026

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
09:57

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens

Published on: February 14, 2011

New inhibitors of complement fixation

M Lapidus, J Tomasco

    Immunopharmacology
    |June 1, 1981
    PubMed

    Abstract:

    A search for compounds that inhibit complement fixation revealed a number of new inhibitors. The presence of EDTA in the phosphate buffer containing complement and compound aided in the detection of compounds that inhibit complement fixation. Compounds were identified as inhibitors that previously could not be shown experimentally to inhibit complement fixation.

    More Related Videos

    Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
    06:29

    Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

    Published on: January 29, 2014

    In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
    07:25

    In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

    Published on: May 4, 2017

    Related Experiment Videos

    Last Updated: Aug 15, 2026

    Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
    09:57

    Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens

    Published on: February 14, 2011

    Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
    06:29

    Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

    Published on: January 29, 2014

    In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
    07:25

    In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

    Published on: May 4, 2017

    Related Concept Videos

    Enzyme Inhibition01:30

    Enzyme Inhibition

    Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
    Antimicrobial Proteins01:23

    Antimicrobial Proteins

    Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
    Interferons
    Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
    Complement System01:27

    Complement System

    The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...

    Articles linked to this work by shared authors, journal, and citation graph.

    Significance of bacteriuria with presumed non-pathogenic organisms.

    The Journal of urology·1980

    Contraction stress test for antepartum fetal evaluation.

    Obstetrics and gynecology·1975

    Purification and concentration of influenza types A and B by chromatography on calcium phosphate.

    Applied microbiology·1969

    Enzymatic preparation and purification of prostaglandin E2.

    Journal of lipid research·1968

    Interleukin 2 maintains biologic stability and sterility over prolonged time.

    Immunopharmacology·2000

    Comparative study of lymphocyte-suppressive potency between prednisolone and methylprednisolone in rheumatoid arthritis.

    Immunopharmacology·2000

    Activation of rat splenic macrophage and lymphocyte functions by fumonisin B1.

    Immunopharmacology·2000

    Sublytic complement attack reduces infarct size in rabbit isolated hearts: evidence for C5a-mediated cardioprotection.

    Immunopharmacology·2000

    Purification and characterization of cytokine-inducing protein of seed extract from Aeginetia indica L., a parasitic plant.

    Immunopharmacology·2000

    Induction of Th1-type cytokines by lipoteichoic acid-related preparation isolated from OK-432, a penicillin-killed streptococcal agent.

    Immunopharmacology·2000

    From serendipitous reaction discovery to antimycobacterial opportunities: general access to scarcely reported 2-((pyrrolin-5-yl)amino)phenols.

    Organic & biomolecular chemistry·2026

    Cannabidiol and Alcohol Use Disorders: An Updated Review of Therapeutic Potential.

    Alcohol, clinical & experimental research·2026

    Molecular Glue Degraders in Early Development for Cancer Therapy.

    Medicinal research reviews·2026

    Anticancer Potential of Antimicrobial Peptides: Mechanisms, Clinical Application, Challenges, and Future Prospects.

    Drug development research·2026

    β-Caryophyllene Mitigates Thioacetamide-Induced Liver Fibrosis Through CB2-Mediated Suppression of Necroptosis: A Therapeutic Investigation.

    Pharmacology research & perspectives·2026

    Network pharmacology, and molecular docking studies for two flavonoid compounds isolated from Dodonaea viscosa towards SARS-CoV-2 infection and loaded in lipid nanoparticles.

    Artificial cells, nanomedicine, and biotechnology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us